Keyphrases
Brain Injury
100%
Traumatic Brain Injury
100%
Hypoxemia
100%
Minocycline
100%
Long-term Functional Outcome
100%
Microglial Activation
28%
Short Course
28%
Neuroprotective
28%
Clinical Trials
14%
Initial Dose
14%
Neuroprotection
14%
Survivors
14%
Neuropathology
14%
Neuronal Loss
14%
Preclinical Trials
14%
Preclinical Efficacy
14%
Synapse Loss
14%
Hippocampal Neurons
14%
Therapeutic Window
14%
Long-term Efficacy
14%
Monocyte Infiltration
14%
Hippocampal Synapses
14%
Primary Injury
14%
Neuroinflammatory Response
14%
Early Administration
14%
Memory Performance
14%
White Matter Myelination
14%
Fear Memory
14%
Hippocampal Neurodegeneration
14%
Human Traumatic Brain Injury
14%
Medicine and Dentistry
Brain Injury
100%
Traumatic Brain Injury
100%
Hypoxemia
100%
Minocycline
100%
Neuroprotective Agent
28%
Neurodegeneration
14%
Clinical Trial
14%
Neuroprotection
14%
Therapeutic Window
14%
Neuropathology
14%
Synapse
14%
Myelination
14%
Experimental Traumatic Brain Injury
14%
Pharmacology, Toxicology and Pharmaceutical Science
Brain Injury
100%
Hypoxemia
100%
Traumatic Brain Injury
100%
Minocycline
100%
Neuroprotective Agent
28%
Clinical Trial
14%
Nerve Degeneration
14%
Therapeutic Window
14%
Neuroprotection
14%
Experimental Traumatic Brain Injury
14%
Neuroscience
Neurotrauma
100%
Traumatic Brain Injury
100%
Minocycline
100%
Neuroprotective Agent
28%
Neurodegeneration
14%
Synapse
14%
Neuroprotection
14%
Myelinogenesis
14%
Immunology and Microbiology
White Matter
100%
Synapse
100%
Myelination
100%